Akihiko Wakatsuki

Prof. Dr. Akihiko Wakatsuki


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2008 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
RNRyuhei Nagai
Ryuhei Nagai
KWKazushi Watanabe
Kazushi Watanabe
AWAkihiko Wakatsuki
Akihiko Wakatsuki
FHFumiaki Hamada
Fumiaki Hamada
KSKoichi Shinohara
Koichi Shinohara
TFTakao Fukaya
Takao Fukaya

20 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AIAyaka Ishikawa
Ayaka Ishikawa
HMHiroshi Matsushita
Hiroshi Matsushita
SSSaki Shimizu
Saki Shimizu
NMNoriko Morita
Noriko Morita
RHRina Hanai
Rina Hanai
AWAkihiko Wakatsuki
Akihiko Wakatsuki
Although estrogen possesses both pro- and anti-oxidant properties, its overall role in oxidative stress among women remains unclear, particularly since the influence of exogenously administered estrogen during previous studies differed by dose, administration route, and estrogen type. The aim of this study was to elucidate the effects of endogenous estrogen on oxidative stress in women. Thus, we performed a non-interventional observational study of healthy postmenopausal (n = 71) and premenopausal (n = 72) female volunteers. Serum levels of derivatives of reactive oxygen metabolites (d-ROMs, which are collectively a marker of oxidative stress), as well as the biological antioxidant potential (BAP, an indicator of antioxidant capacity), were compared between (1) pre- versus post-menopausal women, and (2) premenopausal women in early follicular versus mid-luteal phases of their menstrual cycles. We found that serum d-ROMs and BAP values in postmenopausal women were significantly higher than those in premenopausal women. Moreover, the d-ROM levels were significantly correlated with serum copper concentrations. However, neither d-ROMs nor BAP values were significantly affected by the menstrual cycle phase, although changes in d-ROMs between the follicular and luteal phases were significantly correlated with copper concentration shifts. These data indicate that postmenopausal hypoestrogenism is associated with elevated oxidative stress, although regular fluctuations of estrogen levels during the menstrual cycle do not influence oxidative stress.

1 January 2024 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
AWAkihiko Wakatsuki
Akihiko Wakatsuki
YLYinzhi Lin
Yinzhi Lin
SKShiori Kojima
Shiori Kojima
HMHiroshi Matsushita
Hiroshi Matsushita
KTKosei Takeuchi
Kosei Takeuchi
KUKazuo Umezawa
Kazuo Umezawa
Endometriosis, a common gynecological disorder characterized by the growth of endometrial gland and stroma outside the uterus, causes several symptoms such as dysmenorrhea, hypermenorrhea, and chronic abdominal pain. 17β estradiol (E2) stimulates the growth of endometriotic lesions. Although estetrol (E4), produced by human fetal liver, is also a natural estrogen, it may have the opposite effects on endometriotic cells. We investigated different effects of E4 and E2 on the invasion and migration of immortalized human endometrial stromal cells (HESCs) and evaluated whether E4 affects the expression of Wiskott-Aldrich syndrome protein (WASP) family member 1 (WASF-1). We measured the invasion of HESCs by a Matrigel chamber assay. Cell migration was measured by wound healing assay and cell tracking analysis. The expression of WASF-1 was confirmed by independent real-time PCR analysis. Transfection of cells with siRNAs was carried out to knock down the expression of WASF-1 in HESCs. E4 significantly inhibited E2-induced invasion and migration of HESCs. WASF-1 was found to be a potential mediator based on metastasis PCR array. WASF-1 was upregulated by E2 and downregulated by E4. Knockdown of WASF-1 inhibited migration. Our results suggest that E4 may inhibit E2-induced growth of endometriotic lesions. Downregulation of WASF-1 is involved in the inhibitory effects of E4 on migration. The use of E4 combined with progestins as combined oral contraceptives may cause endometriotic lesions to regress in women with endometriosis.

15 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RHRina Hanai
Rina Hanai
HMHiroshi Matsushita
Hiroshi Matsushita
Akira MinamiAkira Minami
Akira Minami
YAYuki Abe
Yuki Abe
RTRika Tachibana
Rika Tachibana
AWAkihiko Wakatsuki
Akihiko Wakatsuki
Although previous studies have demonstrated that royal jelly (RJ) may have estrogenic properties and prevent postmenopausal bone loss, the underlying mechanisms are not fully understood. This animal study aimed to investigate the effects of specific fatty acids of RJ, 10-hydroxy-2-decenoic acid (10H2DA) and 10-hydroxydecanoic acid (10HDAA), in ovariectomized rats. Ten-week-old female Wistar rats were divided into the Baseline, Sham, Ovx, Ovx + 10H2DA, and Ovx + 10HDAA groups. Rats in the Baseline group were sacrificed immediately, whereas those in the other groups were subjected to either a sham operation or bilateral ovariectomy. The animals in the Ovx + 10H2DA and Ovx + 10HDAA groups were fed diets containing 10H2DA and 10HDAA, respectively. Twelve weeks after surgery, the rats were sacrificed, and indices of bone mass and bone mechanics were analyzed. Femoral bone mineral density was significantly lower in the Ovx group than in the Sham group (p < 0.01). Administration of 10H2DA or 10HDAA did not ameliorate bone loss after ovariectomy. In addition, administration of these fatty acids diminished femur bone stiffness in ovariectomized rats (p < 0.01 and p < 0.05, respectively). These findings suggest that the favorable effects of RJ may not be exerted solely by 10H2DA or 10HDAA. However, these effects may be exhibited in combination with other RJ constituents.

9 June 2023 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
YLYinzhi Lin
Yinzhi Lin
SKShiori Kojima
Shiori Kojima
AIAyaka Ishikawa
Ayaka Ishikawa
HMHiroshi Matsushita
Hiroshi Matsushita
YTYuka Takeuchi
Yuka Takeuchi
AWAkihiko Wakatsuki
Akihiko Wakatsuki
Endometriosis is initiated by the movement of endometrial cells in the uterus to the fallopian tubes, the ovaries and the peritoneal cavity after the shedding of the uterus lining. To cause endometriosis, it is often necessary for these endometrial cells to migrate, invade and grow at the secondary site. In the present study, immortalized human endometriosis stromal cells (HESC) were employed to look for the inhibitors of migration and invasion. Using a chemical library of bioactive metabolites, it was found that an NF‑κB inhibitor, DHMEQ, inhibited the migration and invasion of HESC. Both whole‑genome array and metastasis PCR array analyses suggested the involvement of myosin light chain kinase (MLCK) in the mechanism of inhibition. DHMEQ was confirmed to inhibit the expression of MLCK and small inhibitory RNA knockdown of MLCK reduced cellular migration and invasion. The addition of DHMEQ to the knockdown cells did not further inhibit migration and invasion. DHMEQ is particularly effective in suppressing disease models by intraperitoneal (IP) administration and this therapy is being developed for the treatment of inflammation and cancer. DHMEQ IP therapy may also be useful for the treatment of endometriosis.

1 May 1997 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
YOYuji Okatani
Yuji Okatani
KWKazushi Watanabe
Kazushi Watanabe
KHKazutoshi Hayashi
Kazutoshi Hayashi
AWAkihiko Wakatsuki
Akihiko Wakatsuki
YSYusuke Sagara
Yusuke Sagara